2025

1. Alkabab Y, Rani Y, Farhad M, Zamudio C, Caceres T, Cox H, Dowling W, Nakabugo E, Nakiyingi L, Hoang C, Van Hung N. Diagnostic accuracy of the Cepheid MTB host response assay for the detection of pulmonary TB. IJTLD open. 2025 Nov 12;2(11):646-54.
2. Bonham KS, Margolis ET, Fahur Bottino G, Sobrino AC, Patel F, McCann S, Zieff MR, Miles M, Herr D, Davel L, Bosco C, , Huttenhower C, Pini N, Alexander DC, Jones DK, Williams SCR, Amso D, Gladstone M, Fifer WP, Donald KA, Gabard-Durnam LJ, Klepac-Ceraj V.2025.Codevelopment of gut microbial metabolism and visual neural circuitry over human infancy. mBio16:e00835-25.https://doi.org/10.1128/mbio.00835-25
3. Bottino GF, Bonham KS, Patel F, McCann S, Zieff M, Naspolini N, Ho D, Portlock T, Joos R, Midani FS, Schüroff P. Early life microbial succession in the gut follows common patterns in humans across the globe. bioRxiv. 2024 Jul 26:2024-07.
4. Bukula L, Chengalroyen MD, Omollo C, Moseki RM. Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine. The Microbe. 2025 Mar 1;6:100230.
5. Chengalroyen MD, Oketade N, Worley A, Lucas M, Ramirez LM, Raphela ML, Swarbrick GM, Soma PS, Zuma M, Warner DF, Lewinsohn DA. Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists. PLoS pathogens. 2025 Jul 1;21(7):e1012632.
6. Claassen-Weitz S, Xia Y, Hannan L, Gardner-Lubbe S, Mwaikono KS, Harris Mounaud S, Nierman WC, Workman L, Dube FS, Africa S, Patel F. Nasopharyngeal microbiota in South African infants with lower respiratory tract infection: a nested case-control study of the Drakenstein Child Health Study. Clinical Infectious Diseases. 2025 Apr 17:ciaf184.
7. Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, Lass-Flörl C, Ostrosky-Zeichner L, Rautemaa-Richardson R, Revathi G, Santolaya ME. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. The Lancet Infectious Diseases. 2025 May 1.
8. Cox H, Rani Y, Nakiyingi L, Francia KA, Xie Y, Hoang C, Hapeela N, Romero GP, Nasinghe E, Van Hung N, Kim S. Diagnostic accuracy of a commercial AI digital stethoscope for diagnosis of TB. IJTLD open. 2025 Oct 10;2(10):610-5.
9. Dartois VA, Mizrahi V, Savic RM, Silverman JA, Hermann D, Barry III CE. Strategies for shortening tuberculosis therapy. Nature Medicine. 2025 Jun 13:1-1.
10. Domburg C, Bassa F, Paul L, Swanepoel C. Evaluation of the Cepheid Xpert® BCR-ABL Monitor and Ultra assays used to identify and monitor the presence of the oncogenic p210 BCR:: ABL1 mRNA transcript in chronic myeloid leukaemia patients. The Journal of Medical Laboratory Science and Technology of South Africa. 2025 Jun 1;7(1):34-40.
11. Faisal S, Saqib U. Community series in targeting signalling pathways in inflammatory diseases. Community Series in Targeting Signalling Pathways in Inflammatory Diseases, volume II. 2025 Aug 18:4.
12. Ghebrekristos Y, Ahmed A, Beylis N, Singh S, Opperman C, Naufal F, Folkerts M, Engelthaler D, Auma E, Venter R, Booley G. Xpert MTB/RIF Ultra-resistant and MTBDR plus-susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. Antimicrobial Agents and Chemotherapy. 2025 Mar 5;69(3):e01671-24.
13. Graham AS, Patel F, Little F, van der Kouwe A, Kaba M, Holmes MJ. Using short-read 16S rRNA sequencing of multiple variable regions to generate high-quality results to a species level. Frontiers in Bioinformatics. 2025 Mar 17;5:1484113.
14. Jassat W, Moshabela M, Nicol MP, Dickson L, Cox H, Mlisana K, Black J, Loveday M, Grant AD, Kielmann K, Schneider H. Decentralising DR-TB care: the trade-off between quality of care and service coverage in the early phase of implementation. Public Health Action. 2025 Sep 3;15(3):97-102.
15. Kotzé TJ, Mostert KJ, Domingo R, Wang X, Moolman WJ, Butman HS, Pepin A, McKay KT, Neveling DP, Evans JC, Mizrahi V. Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC’s PPCS Activity in Mycobacterium tuberculosis and Staphylococcus aureus. ACS Infectious Diseases. 2025 Jun 3.
16. Maasdorp E, Ghebrekristos Y, Khumalo A, Paul L, Williams MJ. Non-tuberculosis mycobacteria identified by line probe assays in respiratory and non-respiratory samples in South Africa between 2015 and 2019. Tuberculosis. 2025 Mar 1;151:102610.
17. Magodoro IM, Kotze LA, Stek CJ, West A, Le Roux A, Sobratee N, Taliep A, Hamada Y, Dave JA, Rangaka MX, Parihar SP. Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: Implications and opportunities for therapies. Expert Opinion on Pharmacotherapy. 2025 Jun 13;26(9):1099-112.
18. Moseki RM, Chengalroyen MD. Rethinking BCG vaccine delivery for enhanced efficacy: Are two distinct routes of BCG administration better than one?. hLife. 2025 Jan 13;3(2):61-3.
19. Purohit M, Ssengooba W, Cox H, Ugarte-Gil C, Sserubiri J, Tootla H, Velen K, Szekely R, Penn-Nicholson A. Performance evaluation of the Molbio Diagnostics Truenat™ MTB UltimaPlus/COVID-19 multiplex assay for TB and COVID-19 case detection among people with symptoms suggestive of Tuberculosis-A Study protocol for clinical trial. Frontiers in Public Health. 2025 Jun 27;13:1620210.
20. Rampersadh K, Salie MT, Engel K, Moodley C, Engel ME. Penicillin remains an effective agent against Group A Streptococcus in low-and middle-income countries: A systematic review and meta-analysis of antibiotic resistance and associated genes. South African Medical Journal. 2025 Jul 1;115(7):47-54.
21. Santos JA, Timinskas K, Ramudzuli AA, Lamers MH, Venclovas Č, Warner DF, Gessner SJ. The RecA-NT homology motif in ImuB mediates the interaction with ImuA′, which is essential for DNA damage–induced mutagenesis. Journal of Biological Chemistry. 2025 Feb 1;301(2).
22. Van Den Bergh D, Charani E, Dramowski A, Annor AS, Gijzelaar M, Messina A, Van Jaarsveld A, Goff DA, Prusakov P, Balfour L, Bekker A. Defining and responding to the contextual drivers for implementation of antimicrobial stewardship in 14 neonatal units in South Africa. JAC-Antimicrobial Resistance. 2025 Feb;7(1):dlae222.
23. Wall RJ, Mizrahi V, Lamprecht DA. PurFect timing: revisiting purine metabolism for tuberculosis treatment. Trends in Microbiology. 2025 Nov 6.
24. Warner DF, Barczak AK, Gutierrez MG, Mizrahi V. Mycobacterium tuberculosis biology, pathogenicity and interaction with the host. Nature Reviews Microbiology. 2025 Jun 30:1-7.
25. Xie YL, Modi N, Lopez K, Reiss R, Robledo J, Eichberg C, Hapeela N, Nakabugo E, Anyango I, Arora K, Odero R. Prominence of Mycobacterium tuberculosis biomarkers among sputum culture-negative clinic attendees, independent of Ultra status. Journal of Infection and Public Health. 2025 Apr 24:102791.
26. Yassine I, Jolley KA, Bray JE, Jansen van Rensburg MJ, Patel F, Sheppard AE, Zar HJ, Allen V, Ah Tow L, Maiden MC, Nicol MP. Investigating the population structure of Moraxella catarrhalis using a cgMLST scheme and LIN code system. Nature Communications. 2025 Oct 17;16(1):9137.
27. Zemanay W, Eltholth M, Brink A, Mkrtchyan HV. Advancing one health surveillance in South Africa. Discover Sustainability. 2025 Aug 6;6(1):763.
28. Zinyakatira N, Smith M, Boulle A, Tiffin N, Johnson LF, Ford N, Cox H. Impact of HIV and hospitalization on the incidence of subsequent rifampicin-resistant tuberculosis after initiation of first-line tuberculosis treatment: a retrospective cohort study in South Africa. EClinicalMedicine. 2025 Dec 1;90.

 2023

• Abotsi RE, Dube FS, Rehman AM, Claassen-Weitz S, Xia Y, Simms V, Mwaikono KS, Gardner-Lubbe S, McHugh G, Ngwira LG, Kwambana-Adams B, Heyderman RS, Odland JØ, Ferrand RA, Nicol MP; BREATHE study team. Sputum bacterial load and bacterial composition correlate with lung function and are altered by long-term azithromycin treatment in children with HIV-associated chronic lung disease. Microbiome. 2023;11(1):29.  
• Apolisi I, Cox H, Tyeku N, Daniels J, Mathee S, Cariem R, Douglas-Jones B, Ngambu N,  Mudaly V, Mohr-Holland E, Isaakidis P, Pfaff C, Furin J, Reuter A. Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household. Open Forum Infect Dis. 2023;10(3):ofad087.
• Arakkal A, Centner CM, Hilton T, Nortje M, Held M, Roche S, Brink AJ, Mendelson M, Laubscher M. Developing an antibiogram for empiric antibiotic prescribing for adult non-spinal orthopaedic infections in a developing world setting. Eur J Orthop Surg Traumatol. 2023 Sep 15.
• Bamford C, Blumberg LH, Bosman M, Frean J, Hoek KGP, Miles J, Sriruttan C, Vorster I, Oosthuizen MC.  Neoehrlichiosis in Symptomatic Immunocompetent Child, South Africa.  Emerging Infectious Disease.  2023; 29(2):407-410
• Bobak CA, Botha M, Workman L, Hill JE, Nicol MP, Holloway JW, Stein DJ, Martinez L, Zar HJ. Gene Expression in Cord Blood and Tuberculosis in Early Childhood: A Nested Case-Control Study in a South African Birth Cohort. Clin Infect Dis. 2023 14;77(3):438-449.
• Boshoff HIM, Warner DF, Gold B. Editorial: Drug-resistant Mycobacterium tuberculosis. Front Cell Infect Microbiol. 2023;13:1215294.
• Campaniço A, Harjivan SG, Freitas E, Serafini M, Gaspar MM, Capela R, Gomes P, Jordaan A, Madureira AM, André V, Silva AB, Duarte MT, Portugal I, Perdigão J, Moreira R, Warner DF, Lopes F. Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability. ChemMedChem. 2023;18(24):e202300410.
• Chengalroyen M.  Current Perspectives and Challenges of MAIT Cell-Directed Therapy for Tuberculosis Infection.  Pathogens.  2023; 12(11): 11-12
• Chengalroyen MD, Mehaffy C, Lucas M, Bauer N, Raphela ML, Oketade N, Warner DF, Lewinsohn DA, Lewinsohn DM, Dobos KM, Mizrahi V. Modulation of riboflavin biosynthesis and utilization in mycobacteria. bioRxiv [Preprint]. 2023;2023.08.30.555301
• Claassen-Weitz S, Gardner-Lubbe S, Xia Y, Mwaikono KS, Mounaud SH, Nierman WC, Workman L, Zar HJ, Nicol MP. Succession and determinants of the early life nasopharyngeal microbiota in a South African birth cohort. Microbiome. 2023;11(1):127.
• Derendinger B, Dippenaar A, de Vos M, Huo S, Alberts R, Tadokera R, Limberis J, Sirgel F, Dolby T, Spies C, Reuter A, Folkerts M, Allender C, Lemmer D, Van Rie A, Gagneux S, Rigouts L, Te Riele J, Dheda K, Engelthaler DM, Warren R, Metcalfe J, Cox H, Theron G. Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study. Lancet Microbe. 2023;4(12):e972-e982
• Dheda K, Centner CM, Wilson L, Pooran A, Grimwood S, Ghebrekristos YT, Oelofse S, Joubert IA, Esmail A, Tomasicchio M. Intensive Care Unit Sluice Room Sinks as Reservoirs and Sources of Potential Transmission of Carbapenem-Resistant Bacteria in a South African Tertiary Care Hospital.  Infection and Drug Resistance.  2023; 16: 5427-5432
• Dickson L, Le Roux SR, Mitrani L, Hill J, Jassat W, Cox H, Mlisana K, Black J, Loveday M, Grant A, Kielmann K, Ndjeka N, Moshabela M, Nicol M. Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study. BMJ Open. 2023;13(11):e067121.
• du Preez C, Legoabe LJ, Jordaan A, Jesumoroti OJ, Warner DF, Beteck RM. Arylnitro monocarbonyl curcumin analogues: synthesis and in vitro antitubercular evaluation. Chem Biol Drug Des. 2023; 101(3):717-726.
• Dube PS, Angula KT, Legoabe LJ, Jordaan A, Boitz Zarella JM, Warner DF, Doggett JS, Beteck RM. Quinolone-3-amidoalkanol: A New Class of Potent and Broad-Spectrum Antimicrobial Agent. ACS Omega. 2023;8(19):17086-1710
• Dube PS, Legoabe LJ, Jordaan A, Sigauke L, Warner DF, Beteck RM. Quinolone analogues of benzothiazinone: Synthesis, antitubercular structure-activity relationship and ADME profiling. Eur J Med Chem. 2023;258:115539.
• Gebremicael MN, Nuttall JJC, Tootla HD, Khumalo A, Tooke L, Salie S, Muloiwa R, Rhoda N, Basera W, Eley BS. Candida bloodstream infection among children hospitalised in three public-sector hospitals in the Metro West region of Cape Town, South Africa. BMC Infect Dis. 2023;23(1):67.
• Ghebrekristos YT, Beylis N, Centner CM, Venter R, Derendinger B, Thsivhula H, Naidoo S, Alberts R, Prins B, Tokota A, Dolby T, Marx F, Omar SV, Warren R, Grant T.  Xpert MTB/ RIF ultra on contaminated liquid cultures for tuberculosis and rifamicin-resistance detection: a diagnostic accuracy evaluation.  The Lancet Microbe.  2023; 4(10):e822-829
• Gigi RMS, Mdingi MM, Jung H, Claassen-Weitz S, Bütikofer L, Klausner JD, Muzny CA, Taylor CM, van de Wijgert JHHM, Peters RPH, Low N.  Genital tract infections, the vaginal microbiome and gestational age at birth among pregnant women in South Africa: A cohort study protocol.  BMJ Open. 2023; 13(12): 1-8
• Gizamba JM, Paul L, Dlamini SK, Odayar J.  Incidence and distribution of human leptospirosis in the Western Cape Province, South Africa (2010-2019): a retrospective study.  Pan African Medical Journal. 2023; 44:121
• Goig GA, Menardo F, Salaam-Dreyer Z, Dippenaar A, Streicher L, Daniels J, Reuter A, Borell S, Reinhard M, Doetsch A, Beisel C, Warren RM, Gagneux S, Cox H. Effect of compensatory evolution facilitates the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in a high-endemic setting. Lancet Microbe. 2023; 4:e506-e515
• Hall MB, Rabodoarivelo MS, Koch A, Dippenaar A, George S, Grobbelaar M, Warren R, Walker TM, Cox H, Gagneux S, Crook D, Peto T, Rakotosamimanana N, Grandjean Lapierre S, Iqbal Z. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Lancet Microbe. 2023;4(2):e84-e92.
• Jesumoroti OJ, Beteck RM, Jordaan AE, Warner DF, Legoabe LJ.  Exploration of 4-aminopyrrolo[2,3-d]pyrimidine as antitubercular agents.  Molecular Diversity. 2023; 27: 753-765
• Kapp E, Calitz H, Streicher EM, Dippenaar A, Egieyeh S, Jordaan A, Warner DF, Joubert J, Malan SF, Sampson SL. Discovery and biological evaluation of an adamantyl-amide derivative with likely MmpL3 inhibitory activity. Tuberculosis (Edinb). 2023;141:102350.
• Kekana D, Naicker SD, Shuping L, Velaphi S, Nakwa FL, Wadula J, Govender NP.  Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa.  Emerging Infectious Disease. 2023; 29(10): 2044-2053
• Koller TO, Scheid U, Kösel T, Herrmann J, Krug D, Boshoff HI, Beckert B, Evans JC, Schlemmer J, Sloan. B, Weiner DM, Via LE, Moosa A, Ioerger TR, Gille F, Siebke M, Seedorf T, Plettenburg O, Warnke AL, Ullrich J, Warrass R, Barry CE III, Warner DF, Mizrahi V, Kirschning A, Wilson DN, Müller R. The myxobacterial antibiotic myxovalargin: Biosynthesis, structural revision, total synthesis and molecular characterization of ribosomal inhibition. J Am Chem Soc.  2023;145(2):851-863.  
• Koeppel L, Denkinger CM, Wyss R, Broger T, Chegou NN, Dunty JM, Scott K, Caceres T, Du Toit E, Ugarte-Gill C, Nicol M, Gotuzzo E, Corstjens PLAM, Geluk AK, Sutherland J, sigal GB, Moreau E, Albertini A, Mantsoki A, Ongarello S, Walzl G, Suarez MF.  Diagnostic performance of host protein signatures as a triage test for active pulmonary TB.  Journal of Clinical Microbiology.  2023; 61(10):1-13
• Lakoh S, Kamudumuli PS, Penney ROS, Haumba SM, Jarvis JN, Hassan AJ, Moudoute NLE, Ocansey BK, Izco S, Kipkerich S, Sacarlal J, Awopeju AT, Govender NP, Munyanji CIM, Guyguy K, Orefuwa E, Denning DW.  Diagnostic capacity for invasive fungal infections in advanced HIV disease in Africa: a continent-wide survey.  Lancet Infectious Diseases.  2023; 23:598-608
• Magobo RE, Ismail H, Lowe M, Strasheim W, Mogokotleng R, Perovic O, Kwenda S, Ismail A, Makua M, Bore A, Phayane R, Naidoo H, Dennis T, Ngobese M, Wijnant W, Govender NP.  Outbreak of NDM-1- and OXA-181- Producing Klebsiella pneumoniae Bloodstream Infections in a Neonatal Unit, South Africa.  Emerging Infectious Disease.  2023; 29(8):1531-1539
• Marais G, Hardie D, Brink A. A case for investment in clinical metagenomics in low-income and middle-income countries. Lancet Microbe. 2023 Mar;4(3):e192-e199
• Marais G, Valley-Omar Z, Marais S, McMullen K, Bateman K, der Westhuizen DV, Maseko M, Hardie D, Brink A. Clinical metagenomics in a resource-limited setting. J Infect. 2023;87(6):604-606.
• Martinez L, Gray DM, Botha M, Nel M, Chaya S, Jacobs C, Workman L, Nicol MP, Zar HJ. The Long-Term Impact of Early-Life Tuberculosis Disease on Child Health: A Prospective Birth Cohort Study. Am J Respir Crit Care Med. 2023;207(8):1080-1088.
• Mbamalu O, Surenda S, Nampoothiri V, Bonaconsa C, Edathadathil F, Zhu N, Lambert H, Tarrant C, Ahmad R, Boutall A, Brink A, Steenkamp E, Holmes A, Singh S, Charani E, Mendelson M.  Survey of healthcare worker perceptions of changes in infection control and antimicrobial stewardship practices in India and South Africa during the COVID-19 pandemic.  IJID Regions. 2023 6: 90-98
• Mbamalu O, Surendran S, Nampoothiri V, Bonaconsa C, Edathadathil F, Zhu N, Carter V, Lambert H, Tarrant C, Ahmad R, Brink A, Steenkamp E, Holmes A, Singh S, Charani E, Mendelson M.  A survey of patient and public perceptions and awareness of SARS-CoV-2-related risks among participants in India and South Africa. PLOS Glob Public Health. 2023;3(7):e0001078.
• Middelkoop K, Koch AS, Hoosen Z, Bryden W, Call C, Seldon R, Warner DF, Wood R, Andrews JR. Environmental air sampling for detection and quantification of Mycobacterium tuberculosis in clinical settings: Proof of concept. Infect Control Hosp Epidemiol. 2023;44(5):774-779
• Moodley C, Tootla H, Amien I, Engel ME. Evaluating the utility of the Allplex STI Essential Assay to determine the occurrence of urogenital sexually transmitted infections among symptomatic and asymptomatic patients in Cape Town, South Africa. PLoS One. 2023;18(11):e0292534.
• Naicker SD, Shuping L, Zulu TG, Mpembe RS, Mhlanga M, Tsotetsi EM, Maphanga TG, Govender NP; MMed, FC Path SA, for GERMS-SA. Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa. Med Mycol. 2023;61(6):myad057
• Nzimande SP, Govender NP, Maphanga TG.  In vitro manogepix susceptibility testing of South African Emergomyces africanus, Emergomyces pasteurianus, and Blastomyces emzantsi clinical isolates.  Antimicrobial Agents and Chemotherapy. 2023; 67(12):1-4
• Oderinlo OO, Jordaan A, Seldon R, Isaacs M, Hoppe HC, Warner DF, Tukulula M, Khanye SD. Hydrazone-tethered 5-(Pyridin-4-yl)-4H-1,2,4-triazole-3-thiol hybrids: synthesis, characterisation, in silico ADME studies, and in vitro antimycobacterial evaluation and cytotoxicity. ChemMedChem. 2023;18(6):e202200572
• Omollo C, Singh V, Kigondu E, Wasuna A, Agarwal P, Moosa A, Ioerger TR, Mizrahi V, Chibale K, Warner DF. Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2023;65(5):e02554-20
• Opperman CJ, Singh S, Davids T, Cox H, Warren R, Goosen W. Identifying non- tuberculosis mycobacteria: Is it time to introduce new molecular assays? S Afr Med J. 2023 ;113(6):4-5
• Opperman CJ. Withdrawing antibiotics in the terminally ill ICU patient: Should it be a road less travelled? J Intensive Care Soc. 2023;24(2):234
• Overmeyer AJ, Prentice E, Brink A, Lennard K, Moodley C. The genomic characterization of carbapenem-resistant Serratia marcescens at a tertiary hospital in South Africa. JAC antimicrob Resist. 2023 25;5(4):dlad089
• Paccoud O, Shuping L, Mashau R, Greene G, Quan V, Meiring S, Govender NP; for GERMS-SA. Impact of prior cryptococcal antigen screening on in-hospital mortality in cryptococcal meningitis or fungaemia among HIV-seropositive individuals in South Africa: a cross-sectional observational study. Clin Microbiol Infect. 2023;29(8):1063-1069.
• Peters RPH, Jung H, Mitchev N, Mdingi MM, Gigi R, Shroufi A, Martinez FP, Bamford C. Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa. Sex Transm Dis. 2023;50(12):821-826
• Peters RPH, McIntyre JA, Garrett N, Brink AJ, Celum CL, Bekker LG. Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa. South Afr J HIV Med. 2023;24(1):1510
• Pietersen E, Anderson K, Cox H, Dheda K, Bian A, Shepherd BE, Sterling T, Warren RM, van der Heijden YF. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa. PLoS One. 2023;18(2):e0281097.
• Reddy DL, Nel J, Govender NP. Review: Emergomycosis. J Mycol Med. 2023;33(1):10131
• Reiche MA, Jacobs CA, Aaron JS, Mizrahi V, Warner DF, Chew TL. A comprehensive strategy to strengthen bioimaging in Africa through the Africa Microscopy Initiative. Nat Cell Biol. 2023;25(10):1387-1393.
• Reid M, Agbassi YJP, Arinaminpathy N, Bercasio A, Bhargava A, Bhargava M, Bloom A, attamanchi A, Chaisson R, Chin D, Churchyard G, Cox H, Denkinger CM, Ditiu L, Dowdy D, Dybul M, Fauci A, Fedaku E, Gidado M, Harrington M, Hauser J, Heitkamp P, Herbert N, Herna Sari A, Hopewell P, Kendall E, Khan A, Kim A, Koek I, Kondratyuk S, Krishnan N, Ku CC, Lessem E, McConnell EV, Nahid P, Oliver M, Pai M, Raviglione M, Ryckman T, Schäferhoff M, Silva S, Small P, Stallworthy G, Temesgen Z, van Weezenbeek K, Vassall A, Velásquez GE, Venkatesan N, Yamey G, Zimmerman A, Jamison D, Swaminathan S, Goosby E. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet.  2023;402(10411):1473-1498
• Santos JA, Timinskas K, Lamers MH, Venclovas Č, Warner DF, Gessner SJ. RecA-NT homology motif in ImuB is essential for mycobacterial ImuA'-ImuB protein interaction and mutasome function. bioRxiv [Preprint]. 2023:2023.03.28.534377
• Shawa R, Coomans F, Cox HS, London L.  A promising potential: Using the right to enjoy the benefits of the scientific progress to advance public health in Africa.  African Human Rights Law Journal.  2023; 23:30-47
• Shuping L, Maphanga TG, Naicker SD, Mpembe R, Ngoma N, Velaphi S, Nakwa F, Wadula J, Jaglal P, Govender NP.  High Prevalence of Candida auris Colonization during Protracted Neonatal Unit Outbreak, South Africa.  Emerging Infectious Disease.  2023; 29(9); 1913-1916
• Van der Westhuyzen M, Samodien N, Brink AJ, Moodley C.  Utility of the BioFire® FilmArray® Pneumonia Panel plus assay for syndromic testing of lower respiratory tract infections in a low/middle-income setting.  JAC- Antimicrobial Resistance.2023;5(1) dlac139
• Wake RM, Molloy SF, Jarvis JN, Harrison TS, Govender NP. Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications. Clin Infect Dis. 2023;76(4):764-770.
• Warner DF, Wood R. New tricks for an old dog: opportunities for better tuberculosis control. J Int AIDS Soc. 2023; 26(3):e26081
• WARNINNG Collaborators.  Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action.  2023 18(1): 50
• Winkler KR, Mizrahi V, Warner DF, De Wet TJ. High-throughput functional genomics:  (myco)bacterial perspective. Mol Microbiol. 2023;120(2):141-158  
• Wojno J, Rebe K, van deer Plas H, Hlazo M, Poole t, Cass S, van der Merwe F, Laubscher M, Opperman C, Singh S, Abrahams R, Curle P, Hilton T, Laubscher M, Scott E, Smythe W, Brink A.  Bactreriophages – an introduction to laboratory aspects: a laboratory-based study in South Africa.  2023 5: 84-89.
• Yang Q, Kamat S, Mohamed N, Valdez RR, Lin S, Su M, Quintana A, Kiratisin P, Rodriguez-Zulueta AP, Brink A.  Antimicrobial susceptibility amaong gram-negative isolates in pediatric patients in :atin America, Africa-Middle East and Asia from 2016-2020 compared to 2011-2015: Results from the ATLAS surveillance study.  Journal of the Pediatric Infectious Diseases Society.  2023 12(8):459-470
• Yoon H, Wake RM, Nakouzi AS, Wang T, Agalliu I, Tiemessen CT, Govender NP, Jarvis JN, Harrison TS, Pirofski LA. Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease. Clin Infect Dis. 2023;76(4):649-657
• Young Lee S, Gill CM, Nicolau DP, Brink AJ on behalf of ERACE-PA Global study group.  Activity of novel B-lactam/B-lactamase inhibitor combinations against serine carbapenemase producing carbapenem-resistant pseudomonas aeruginosa.  Journal of Antimicrobial Chemotherapy. 2023 78(12): 2795-2800
• Zwyer M, Rutaihwa LK, Windels E, Hella J, Menardo F, Sasamalo M, Sommer G, Schmülling L, Borrell S, Reinhard M, Dötsch A, Hiza H, Stritt C, Sikalengo G, Fenner L, De Jong BC, Kato-Maeda M, Jugheli L, Ernst JD, Niemann S, Jeljeli L, Ballif M, Egger M, Rakotosamimanana N, Yeboah-Manu D, Asare P, Malla B, Dou HY, Zetola N, Wilkinson RJ, Cox H, Carter EJ, Gnokoro J, Yotebieng M, Gotuzzo E, Abimiku A, Avihingsanon A, Xu ZM, Fellay J, Portevin D, Reither K, Stadler T, Gagneux S, Brites D. Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania. PLoS Pathog. 2023 Apr 4;19(4):e1010893.